Importantly, here we show that the unchecked production of GM-CSF during chronic colitis is a key driver of the eosinophil switch from a resident and homeostatic phenotype (Siglec-Fint) to an over-activated and tissue toxic phenotype (Siglec-Fhi). This evidence concerns the gene CSF2 and Chronic colitis.